RBC Capital Upgrades Extendicare to Outperform, Raises Price Target to C$25

Benzinga · 2d ago
RBC Capital analyst Pammi Bir upgrades Extendicare (TSX:EXE) from Sector Perform to Outperform and raises the price target from C$15 to C$25.